Patient-initiated blood tests and imaging are becoming easier to access, raising questions about clinical oversight and the downstream impact on the system [Image: alashi on iStock (edited)]
Private providers are selling wellness scans and direct-toconsumer tests as a way to “get ahead of the drama”. Orna McGinn says the evidence tells a different story
References
1. Astra Wellness Scans. YouTube.
2. BODYiQ. Hormone Bundle Female.
3. Andermann A, Blancquaert I, Beauchamp S, et al. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008 Apr;86(4):317-9. doi: 10.2471/blt.07.050112. PMID: 18438522; PMCID: PMC2647421.
4. O’Sullivan J, Muntinga T, Grigg S, et al. Prevalence and outcomes of incidental imaging findings: umbrella review. BMJ. 2018;361:k2387. doi:10.1136/bmj.k2387
5. Ganguli I, Simpkin AL, Lupo C, et al. Cascades of care after incidental findings in a US national survey of physicians. JAMA Network Open. 2019;2(10):e1913325.
6. Te Tiratū Iwi Māori Partnership Board. Priority 6: Key insights – identification and treatment pathways for cancers. June 2025.
7. Canadian Institute for Health Information; Choosing Wisely Canada. Unnecessary care in Canada. Ottawa: CIHI; 2017.